{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T18:49:53Z","timestamp":1771872593008,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess the efficacy of progestogens for maintenance tocolysis in women undelivered after their first preterm labor episode.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>Women with singleton pregnancies between 22 0\/7 and 31 6\/7 weeks of gestation with arrested preterm labor and a cervical length 25 mm or less at hospital discharge were eligible. Patients with a previous preterm birth were excluded. In a randomized controlled trial conducted in five university hospitals, women were randomized to receive vaginal progesterone (200 mg per day) or intramuscular 17\u03b1-hydroxyprogesterone caproate (341 mg per week) or to an observation groups (control group). The primary outcome was the proportion of women with preterm birth at less than 37 weeks of gestation. A sample size of 160 per group (n=480) was planned to compare vaginal progesterone and 17\u03b1-hydroxyprogesterone caproate groups with those in the control group. The sample size estimation was based on the hypothesis that the risk of experiencing preterm birth in the control group would be 30% and that 17\u03b1-hydroxyprogesterone caproate or progesterone would decrease this risk to 15%. A <jats:italic toggle=\"yes\">P<\/jats:italic> value of &lt;.025 was defined as statistically significant. At planned interim analysis (n=254), the trial was stopped for futility.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Between July 2010 and June 2015, 257 women were eligible and 254 were subsequently randomly assigned to vaginal progesterone (n=86), 17\u03b1-hydroxyprogesterone caproate (n=87), or observation (n=81). Nineteen (8%) were excluded from the analysis because they either dropped out or information was missing, leaving 235 women available for analysis. Demographic characteristics were similar across groups. The preterm birth rate did not differ significantly between groups: 23% in the 17\u03b1-hydroxyprogesterone caproate group, 39% in the vaginal progesterone group, and 22% in the women in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>=.949 for 17\u03b1-hydroxyprogesterone caproate compared with the women in the control group and <jats:italic toggle=\"yes\">P<\/jats:italic>=.027 for vaginal progesterone compared with women in the control group).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>The use of progestogens for maintenance tocolysis in women with a short cervix did not reduce the rate of preterm birth.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n            <jats:p>\n                                 ClinicalTrials.gov, NCT01178788.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000002065","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T10:34:28Z","timestamp":1496918068000},"page":"64-70","source":"Crossref","is-referenced-by-count":15,"title":["Progestogens for Maintenance Tocolysis in Women With a Short Cervix"],"prefix":"10.1097","volume":"130","author":[{"given":"Fabio","family":"Facchinetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Vergani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariarosaria","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Marozio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Acaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrezia","family":"Pignatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Spitaleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Zaina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the PROTECT Collaborative Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth \u2264 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"351.e1\u2013","DOI":"10.1016\/j.ajog.2010.02.019","article-title":"17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length","volume":"202","author":"Berghella","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17alpha-hydroxyprogesterone caproate [published erratum appears in N Engl J Med 2003;349:1299]","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/AOG.0b013e31822ad6aa","article-title":"17\u03b1-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial","volume":"118","author":"Lim","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/1471-0528.13032","article-title":"Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis","volume":"122","author":"Schuit","year":"2015","journal-title":"BJOG"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3109\/01443615.2013.820266","article-title":"Progesterone use after successful treatment of threatened pre-term delivery","volume":"33","author":"Areia","year":"2013","journal-title":"J Obstet Gynaecol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/1471-0528.13061","article-title":"Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial","volume":"122","author":"Martinez de Tejada","year":"2015","journal-title":"BJOG"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/1471-0528.13956","article-title":"Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"123","author":"Palacio","year":"2016","journal-title":"BJOG"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ajog.2015.03.031","article-title":"Vaginal progesterone for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Suhag","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ajog.2015.01.054","article-title":"17-alpha-hydroxyprogesterone caproate for maintenance tocolysis: a systematic review and metaanalysis of randomized trials","volume":"213","author":"Saccone","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00003081-200312000-00026","article-title":"Ultrasound assessment of the cervix","volume":"46","author":"Berghella","year":"2003","journal-title":"Clin Obstet Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of 17-alpha-hydroxyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/AOG.0b013e3182699a15","article-title":"Progestogens for preterm birth prevention: a systematic review and meta-analysis","volume":"120","author":"Likis","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/AOG.0000000000001676","article-title":"Progestogens as maintenance treatment in arrested preterm labor: a systematic review and meta-analysis","volume":"128","author":"Palacio","year":"2016","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201707000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:37:45Z","timestamp":1689089865000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201707000-00010"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002065","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}